VEGF-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease.

Pia Davidsson,Susanna Eketjäll,Niclas Eriksson,Anna Walentinsson,Richard C Becker,Anders Cavallin,Anna Bogstedt,Anna Collén,Claes Held,Stefan James,Agneta Siegbahn,Ralph Stewart,Robert S Storey,Harvey White,Lars Wallentin

Cardiovascular research（2023）

引用 1|浏览38

暂无评分

摘要

This is the first large-scale cohort study to demonstrate that both VEGF-D plasma levels and VEGFD genetic variants are independently associated with CV outcomes in patients with ACS and CCS. Measurements of VEGF-D levels and/or VEGFD genetic variants may provide incremental prognostic information in patients with ACS and CCS.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要